An important focus of our research into Tourette syndrome over the last few years has been to understand how the brain networks that give rise to tics could be effectively modified or controlled using non-invasive forms of brain stimulation so as to bring about a reduction in tics.
Total raised: $3.2M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.03.2024 | Seed | $3.2M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 18.03.2024 | Neupulse Raises $3.2M in Seed Funding | Neupulse (the trading name for Neurotherapeutics Ltd.), a Nottingham, UK-based health tech company f... | finsmes.co... |
| - | Neupulse | “An important focus of our research into Tourette syndrome over the last few years has been to under... | fastfounde... |